CATALAYER NEWS
Fate Therapeutics receives $15m CIRM grant for lupus trial
Source: Investing.com · 2026-09-25
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Wells Fargo reiterates Equal Weight on Sherwin-Williams stock
2026-09-25
BofA raises Akamai stock price target on $11.6B Anthropic deal
2026-09-25
BofA cuts Grab stock price target on valuation, keeps buy rating
2026-09-25
Guggenheim raises Damora Therapeutics price target on MF sales outlook
2026-09-25
Zambia’s Maamba solar project begins power delivery to grid
2026-09-25
RELATED MARKETS
Prediction Markets